Dihexa Peptide: The Nootropic Peptide Explained

Published April 2026 | Nootropic Guides

Eight week protocols are the most commonly reported, which is long enough for a user to form a view and far too short and uncontrolled to establish anything.

What Dihexa Is Supposed to Do

Best vendor for dihexa right now: Amino Club

10mg vial, $59.99 per vial ($6.00 per mg), list price checked 2026-09-08. The vendor Bureau readers order from most this year, lowest price per mg on most of what we track, batch COA on every product page. Partner code 100 at checkout takes 20% off a first order there, and keeps the order counted for the Bureau. Research use only.

Check price at Amino Club Compare all vendors

Dihexa (full chemical name N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic angiotensin IV analog developed by Joseph Harding's group at Washington State University. It is a small peptide derivative, not a heptapeptide. The proposed primary mechanism is hepatocyte growth factor (HGF) / c-Met receptor activation, with downstream effects on synaptogenesis and neuroplasticity. Some preclinical work has reported BDNF-related downstream effects, but the cleanest mechanistic story in the published literature is HGF/c-Met, not direct BDNF agonism.

Animal studies on Dihexa show promise for cognitive endpoints in rodent models of cognitive impairment. The problem is human studies are essentially nonexistent, there are no peer-reviewed human efficacy trials. What we know comes from chemistry/pharmacology research from the Harding lab and people's anecdotal experience. This is important context for why Dihexa remains a niche compound.

Dihexa Protocols in Circulation

Dihexa is sold as a lyophilised powder. Reported dosing sits between 100mcg and 200mcg daily, most often subcutaneously, though there is no human dose-ranging study to anchor any of it. Those figures come from community practice, not from a trial.

Not sure which of these you actually need?

Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the six vendors we score.

Build your stack, 2 minutes

A typical structure is 100mcg daily with one rest day a week, reconstituted to a concentration that makes the draw readable on an insulin syringe. Daily dosing is used because of the short half-life; less frequent schedules are generally considered unlikely to maintain exposure.

Week-by-week observations:

Weeks 1-2: Nothing obvious. Maybe slightly better focus, but could be placebo or caffeine timing.

Weeks 3 to 4: reports describe subtle change at best, most often longer sustained focus. This is also the window in which expectation effects are hardest to rule out.

Weeks 5 to 6: the point at which change is most commonly described, usually as easier verbal fluency and faster problem solving.

Weeks 7 to 8: continued but undramatic. Reports consistently describe measurable rather than transformative differences.

Get the Dispatch

One research note, one vendor deal, once a week. Free dosing guide on confirm.

Double opt-in. Unsubscribe with one click. Research use only.

Honest Assessment

Dihexa is not a nootropic like Adderall or caffeine. There's no rush, no obvious energy boost, no euphoria. The effects, if they exist, are subtle and cumulative.

The honest summary of the anecdotal record is that reported effects are modest, slow to appear and subjective. Cognitive self-assessment is among the least reliable kinds of self-report, because the faculty doing the assessing is the one supposedly being altered.

On cost, Dihexa is not cheap for a compound with no human efficacy data, and a reasonable person can look at the same evidence and reach the opposite conclusion about whether it is worth running.

Side Effects

Side effects are rarely reported. Mild headache or fatigue in the first week appears occasionally and usually settles. The absence of reported side effects should not be read as an established safety profile: there are no human safety trials, and a compound that promotes synapse formation is not one where the absence of short-term complaints tells you much about long-term effects.

Dosing Considerations

Most users stay at the lower end at 100mcg. More is not obviously better for a compound acting on synaptogenesis, and with no dose-response data the conservative end is the defensible one.

Daily dosing is necessary because of the short half-life, and every-other-day schedules are generally considered inadequate. In practice the main difficulty people report is adherence rather than tolerability, which argues for tying the injection to a fixed point in the morning routine.

The Big Question: Is It Real or Placebo?

This is the part that matters most. Dihexa has no human clinical trials. The animal work is interesting but preclinical, and everything else is anecdote collected without controls, blinding or a comparison group. Reported improvements are entirely compatible with expectation, with better sleep, or with the general effect of paying closer attention to one's own cognition for eight weeks.

There is also a specific reason for caution rather than only uncertainty. The proposed mechanism is potent promotion of new synaptic connections, and a compound that does that indiscriminately is not obviously benign over long periods. No human has been followed long enough to know. Anyone researching it should weigh an unproven upside against an uncharacterised risk, rather than against no risk at all.

Where to Source It

Dihexa stocks come and go. Of the vendors we track, Apollo Peptide Sciences has carried it most reliably with a third-party COA attached to the order, and Pantheon Peptides lists it at a lower price point when available. Verify COA before dosing.

Quality matters here more than with most peptides. You are already working with a compound that is hard to measure subjectively. A weak or impure sample makes it impossible to tell whether the compound itself is doing anything.

Check Apollo Check Pantheon

Key Takeaways

Dihexa is an angiotensin IV analog (Harding lab, WSU) with rodent-model data and effectively no human studies
Effects are subtle and cumulative, not immediate
100-200mcg daily is standard dosing
Cognitive improvements are real but measurable rather than dramatic
No significant side effects reported
Requires daily dosing due to short half-life
Value is in enhanced focus, learning, and memory retention
Honest uncertainty: effects might be real or might be placebo
Cost is low relative to other peptides, so low-risk experiment

Lars Emanuelsen, editor. Peptide Bureau is a small independent research team covering peptide dosing, safety and vendors. We are not clinicians; nothing here is medical advice. How the Bureau works.